EUVIMEDEUVIMED entdecken
Crossref

Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis

Zhe Zhang, Xiaomin Zheng, Chuyu Dong, Pengru Li, Yi Lin, Zhenzhu Sun, Wenjing Li, Xiaoxiao Liu, Jing Li, Shan Li, Bing Gu iD, Lei Zhang iD

Journal of Medicinal Chemistry · 28.05.2026 · 69 (10) · 11872-11899

DOI: 10.1021/acs.jmedchem.5c03220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.05.2026. Verfasst von Zhe Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), South China University of Technol…. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Drug Discovery, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Zhongshan Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Cytoplasmic and NuclearDrug DiscoveryFatty LiverReceptor, Farnesoid X-ActivatedAnimalsHumansRatsMaleStructure-Activity RelationshipReceptors, G-Protein-Coupled

Substanzen

Receptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), South China University of Technology, Guangzhou 510000, China.
  • Department of Clinical Laboratory Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510000, China.
  • MOE International Joint Lab for Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, China.

ORCID-Profile: Bing Gu, Lei Zhang

Förderung

  • Zhongshan Science and Technology Bureau

Zitieren

APA

Zhang, Z., Zheng, X., Dong, C., Li, P., Lin, Y., Sun, Z., Li, W., Liu, X., Li, J., Li, S., Gu, B., & Zhang, L. (2026). Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis. Journal of Medicinal Chemistry, 69(10), 11872-11899. https://doi.org/10.1021/acs.jmedchem.5c03220

Vancouver

Zhang Z, Zheng X, Dong C, Li P, Lin Y, Sun Z, et al. Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis. Journal of Medicinal Chemistry. 2026;69(10):11872-11899. doi:10.1021/acs.jmedchem.5c03220

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhe and Zheng, Xiaomin and Dong, Chuyu and Li, Pengru and Lin, Yi and Sun, Zhenzhu and Li, Wenjing and Liu, Xiaoxiao and Li, Jing and Li, Shan and Gu, Bing and Zhang, Lei},
  title = {Discovery of Non-Carboxylic Steroidal FXR Agonist as a Promising Preclinical Candidate for Metabolic Dysfunction-Associated Steatohepatitis},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {10},
  pages = {11872--11899},
  doi = {10.1021/acs.jmedchem.5c03220}
}
Kostenlos starten →